Inventor · disambiguated record
Steven James Stanway
Also filed as: STANWAY STEVEN J · STANWAY STEVEN JAMES · STANWAY Steven
24 granted patents·20 pending applications·214 citations·filing 1999–2025
95Inventor score
Files withCONVERGENCE PHARMACEUTICALS10SMITHKLINE BEECHAM PLC8GLAXO GROUP LTD7BICYCLETX LTD3NEW PHARMA LICENCE HOLDINGS LTD3
Top patents by PatentIndex Score
44 records- 0193US7253198B2Hydroxyethylamine derivatives for the treatment of Alzheimer's diseaseGLAXO GROUP LTD·Filed 2003·Granted Aug 7, 2007·70 cites·16 claims
- 0292US7960563B2Indazoles used to treat estrogen receptor beta mediated disordersGLAXO GROUP LTD·Filed 2008·Granted Jun 14, 2011·33 cites·3 claims
- 0392US7470694B25,6-trimethylenepyrimidin-4-one compoundsSMITHKLINE BEECHAM PLC·Filed 2006·Granted Dec 30, 2008·11 cites·6 claims
- 0492US7153861B25,6 -Trimethylenepyrimidin-4-one compoundsSMITHKLINE BEECHAM PLC·Filed 2003·Granted Dec 26, 2006·27 cites·4 claims
- 0589US7652019B25,6-trimethylenepyrimidin-4-one compoundsSMITHKLINE BEECHAM PLC·Filed 2009·Granted Jan 26, 2010·6 cites·11 claims
- 0687US7638520B2Pyrimidine compoundsSMITHKLINE BEECHAM PLC·Filed 2006·Granted Dec 29, 2009·6 cites·65 claims
- 0785US9737536B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Granted Aug 22, 2017·3 cites·13 claims
- 0885US6992103B2Benzamide derivatives, processes for their preparation, and their pharmaceutical useSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jan 31, 2006·30 cites·25 claims
- 0984US9376445B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Jun 28, 2016·4 cites·11 claims
- 1083US10010551B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2017·Granted Jul 3, 2018·2 cites·10 claims
- 1183US9309254B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Apr 12, 2016·4 cites·24 claims
- 1283US9266841B2CompoundsGLAXO GROUP LTD·Filed 2014·Granted Feb 23, 2016·3 cites·22 claims
- 1379US10485801B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2018·Granted Nov 26, 2019·1 cites·14 claims
- 1477US8871775B2CompoundsHICKEY DEIRDRE MARY BERNADETTE·Filed 2011·Granted Oct 28, 2014·3 cites·22 claims
- 1576US7235566B2Pyridinone derivatives for treatment of atherosclerosisSMITHKLINE BEECHAM PLC·Filed 2004·Granted Jun 26, 2007·8 cites·20 claims
- 1676US2024391959A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 1772US2020289508A1Novel pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 1871US8314147B2Benzamide derivatives as EP4 receptor agonistsGAIBA ALESSANDRA·Filed 2007·Granted Nov 20, 2012·2 cites·2 claims
- 1971US2025340595A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2025·Application pending·0 cites
- 2071US2023322858A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2170US2009170877A15,6-Trimethylenepyrimidin-4-one compoundsSMITHKLINE BEECHAM PLC·Filed 2009·Application pending·0 cites
- 2267US9376436B22-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorsCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Jun 28, 2016·1 cites·12 claims
- 2366US11970555B2Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)BICYCLETX LTD·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 2463US2023340026A1CompoundsNEW PHARMA LICENCE HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 2559US9303032B22-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Apr 5, 2016·0 cites·7 claims
- 2659US2021221848A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2759US2016184306A1Novel Pyrimidinyl-DiazoSpiro CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 2859US2024382605A1Conjugated oligonucleotides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2957US2025243219A1Macrocyclic compounds and uses thereofCYPRALIS LTD·Filed 2023·Application pending·0 cites
- 3055US2010144765A15,6-trimethylenepyrimidin-4-one compoundsHICKEY DEIDRE MARY BERNADETTE·Filed 2010·Application pending·0 cites
- 3153US2002103213A1Novel compoundsFiled 2001·Application pending·0 cites
- 3251US8536182B2Benzylpiperazine derivatives and their medical useJOHNSON CHRISTOPHER NORBERT·Filed 2006·Granted Sep 17, 2013·0 cites·16 claims
- 3351US7956083B2CompoundsGLAXO GROUP LTD·Filed 2009·Granted Jun 7, 2011·0 cites·3 claims
- 3451US2013317041A1CompoundsGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
- 3549US2016185758A12-(Pyridin-2-yl)-1, 7-Diaza-Spiro [4.4] Nonane-6-One Compound as Voltage-Gated Sodium Channel ModulatorCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 3647US2004063753A1Pyridinone derivatives for treatment of atherosclerosisFiled 2001·Application pending·0 cites
- 3746US12146004B2Polymyxin compounds and uses thereofNEW PHARMA LICENCE HOLDINGS LTD·Filed 2015·Granted Nov 19, 2024·0 cites·26 claims
- 3846US2013261185A1Benzamide Derivatives As EP4 Receptor AgonistsGLAXO GROUP LTD·Filed 2012·Application pending·0 cites
- 3944US2017073373A1Polymyxin derivatives and their use in combination therapy together with different antibioticsNEW PHARMA LICENCE HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 4043US2005033052A1Novel compoundsFiled 2002·Application pending·0 cites
- 4142US11904020B2Bicyclic peptide ligands specific for TREM2BICYCLE TX LTD·Filed 2022·Granted Feb 20, 2024·0 cites·12 claims
- 4242US2008312209A1Piperazine Heteroaryl Derivatives as Gpr38 AgonistsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 4341US2005043335A1Heterocyclic derivatives of glycinamide and their medical useFiled 2002·Application pending·0 cites
- 4430US6441167B1Cinoxacin lanthanide chelates and their use as biomolecular probesSMITHKLINE BEECHAM PLC·Filed 1999·Granted Aug 27, 2002·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Steven James Stanway files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →